Agilon Net Debt from 2010 to 2024

AGL Stock

USD 2.26 0.37 19.58%

Agilon Health Net Debt yearly trend continues to be quite stable with very little volatility. The value of Net Debt is projected to decrease to about -58 M. Net Debt is the total debt of agilon health minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2018-12-31

Previous Quarter

-70.2 M

Current Value

-104.3 M

Quarterly Volatility

376.3 M

Covid

Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 936.1 K, Interest Income of 5.6 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or PTB Ratio of 8.14. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.

Check out the analysis of Agilon Health Correlation against competitors.

For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

Latest Agilon Health's Net Debt Growth Pattern

Below is the plot of the Net Debt of agilon health over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Agilon Health's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agilon Health's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Agilon Net Debt Regression Statistics

	Arithmetic Mean	(136,614,137)
	Coefficient Of Variation	(189.43)
	Mean Deviation	156,266,364
	Median	(45,712,000)
	Standard Deviation	258,785,734
	Sample Variance	66970.1T
	Range	958.1M
	R-Value	(0.37)
	Mean Square Error	62460.4T
	R-Squared	0.13
	Significance	0.18
	Slope	(21,179,176)
	Total Sum of Squares	937580.8T

Agilon Net Debt History

	2024	-58 M
	2023	-55.3 M
	2022	-453.6 M
	2021	-991.6 M
	2020	-33.6 M

Other Fundumenentals of agilon health

Net Debt To E B I T D A

Agilon Health Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Long Term Debt Total	Capital Surpluse	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Cash And Equivalents	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Investments	Current Deferred Revenue
Total Assets		0.97	0.98	-0.63	-0.92	0.54	-0.98	0.82	-0.61	-0.99	0.99	0.43	0.97	0.97	1.0	1.0	0.89	0.94	0.87	-0.66	1.0	-0.48	0.66	-0.6
Total Stockholder Equity	0.97		0.95	-0.77	-0.84	0.37	-0.93	0.7	-0.43	-0.94	0.96	0.21	1.0	0.9	0.98	0.98	0.93	0.99	0.74	-0.64	0.98	-0.55	0.5	-0.43
Net Tangible Assets	0.98	0.95		-0.58	-0.97	0.64	-0.99	0.88	-0.67	-0.98	0.95	0.43	0.95	0.96	0.97	0.99	0.88	0.92	0.85	-0.75	0.99	-0.57	0.75	-0.69
Net Debt	-0.63	-0.77	-0.58		0.36	0.2	0.5	-0.14	-0.12	0.54	-0.63	0.37	-0.78	-0.49	-0.64	-0.63	-0.86	-0.83	-0.26	0.47	-0.63	0.67	0.1	-0.13
Retained Earnings	-0.92	-0.84	-0.97	0.36		-0.8	0.97	-0.97	0.8	0.96	-0.89	-0.6	-0.84	-0.95	-0.92	-0.93	-0.76	-0.8	-0.89	0.77	-0.93	0.5	-0.88	0.83
Accounts Payable	0.54	0.37	0.64	0.2	-0.8		-0.67	0.92	-0.96	-0.63	0.51	0.85	0.36	0.68	0.53	0.55	0.33	0.29	0.78	-0.6	0.55	-0.27	0.98	-0.99
Long Term Debt	-0.98	-0.93	-0.99	0.5	0.97	-0.67		-0.91	0.72	1.0	-0.97	-0.54	-0.93	-0.99	-0.98	-0.99	-0.83	-0.88	-0.91	0.71	-0.99	0.47	-0.78	0.72
Net Receivables	0.82	0.7	0.88	-0.14	-0.97	0.92	-0.91		-0.9	-0.88	0.78	0.74	0.69	0.89	0.81	0.83	0.6	0.63	0.89	-0.7	0.83	-0.38	0.97	-0.93
Good Will	-0.61	-0.43	-0.67	-0.12	0.8	-0.96	0.72	-0.9		0.69	-0.62	-0.91	-0.43	-0.77	-0.61	-0.61	-0.4	-0.34	-0.89	0.51	-0.61	0.22	-0.95	0.98
Long Term Debt Total	-0.99	-0.94	-0.98	0.54	0.96	-0.63	1.0	-0.88	0.69		-0.98	-0.51	-0.94	-0.98	-0.99	-0.99	-0.85	-0.9	-0.9	0.69	-0.99	0.47	-0.74	0.68
Capital Surpluse	0.99	0.96	0.95	-0.63	-0.89	0.51	-0.97	0.78	-0.62	-0.98		0.45	0.96	0.98	0.99	0.98	0.89	0.92	0.89	-0.6	0.98	-0.45	0.63	-0.58
Total Liab	0.43	0.21	0.43	0.37	-0.6	0.85	-0.54	0.74	-0.91	-0.51	0.45		0.2	0.59	0.42	0.4	0.11	0.09	0.78	-0.26	0.4	0.1	0.82	-0.85
Net Invested Capital	0.97	1.0	0.95	-0.78	-0.84	0.36	-0.93	0.69	-0.43	-0.94	0.96	0.2		0.9	0.97	0.98	0.93	0.99	0.74	-0.64	0.98	-0.55	0.5	-0.43
Short Long Term Debt	0.97	0.9	0.96	-0.49	-0.95	0.68	-0.99	0.89	-0.77	-0.98	0.98	0.59	0.9		0.97	0.97	0.84	0.85	0.96	-0.65	0.97	-0.45	0.77	-0.74
Total Current Assets	1.0	0.98	0.97	-0.64	-0.92	0.53	-0.98	0.81	-0.61	-0.99	0.99	0.42	0.97	0.97		1.0	0.89	0.94	0.86	-0.66	1.0	-0.49	0.65	-0.59
Capital Stock	1.0	0.98	0.99	-0.63	-0.93	0.55	-0.99	0.83	-0.61	-0.99	0.98	0.4	0.98	0.97	1.0		0.89	0.95	0.85	-0.69	1.0	-0.52	0.67	-0.6
Cash And Equivalents	0.89	0.93	0.88	-0.86	-0.76	0.33	-0.83	0.6	-0.4	-0.85	0.89	0.11	0.93	0.84	0.89	0.89		0.94	0.69	-0.72	0.89	-0.76	0.41	-0.4
Net Working Capital	0.94	0.99	0.92	-0.83	-0.8	0.29	-0.88	0.63	-0.34	-0.9	0.92	0.09	0.99	0.85	0.94	0.95	0.94		0.65	-0.66	0.95	-0.6	0.42	-0.35
Short Term Debt	0.87	0.74	0.85	-0.26	-0.89	0.78	-0.91	0.89	-0.89	-0.9	0.89	0.78	0.74	0.96	0.86	0.85	0.69	0.65		-0.54	0.85	-0.31	0.84	-0.84
Intangible Assets	-0.66	-0.64	-0.75	0.47	0.77	-0.6	0.71	-0.7	0.51	0.69	-0.6	-0.26	-0.64	-0.65	-0.66	-0.69	-0.72	-0.66	-0.54		-0.69	0.88	-0.6	0.59
Common Stock	1.0	0.98	0.99	-0.63	-0.93	0.55	-0.99	0.83	-0.61	-0.99	0.98	0.4	0.98	0.97	1.0	1.0	0.89	0.95	0.85	-0.69		-0.52	0.67	-0.6
Property Plant Equipment	-0.48	-0.55	-0.57	0.67	0.5	-0.27	0.47	-0.38	0.22	0.47	-0.45	0.1	-0.55	-0.45	-0.49	-0.52	-0.76	-0.6	-0.31	0.88	-0.52		-0.25	0.29
Long Term Investments	0.66	0.5	0.75	0.1	-0.88	0.98	-0.78	0.97	-0.95	-0.74	0.63	0.82	0.5	0.77	0.65	0.67	0.41	0.42	0.84	-0.6	0.67	-0.25		-0.98
Current Deferred Revenue	-0.6	-0.43	-0.69	-0.13	0.83	-0.99	0.72	-0.93	0.98	0.68	-0.58	-0.85	-0.43	-0.74	-0.59	-0.6	-0.4	-0.35	-0.84	0.59	-0.6	0.29	-0.98

Click cells to compare fundamentals

About Agilon Health Financial Statements

Agilon Health investors utilize fundamental indicators, such as Net Debt, to predict how Agilon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-55.3 M	-58 M
Net Debt To EBITDA	0.33	0.31

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether agilon health is a strong investment it is important to analyze Agilon Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Agilon Health's future performance. For an informed investment choice regarding Agilon Stock, refer to the following important reports:

How To Invest In Agilon

Details

Is Agilon Stock a good investment?

Details

What is Agilon Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Agilon Health Correlation against competitors.

For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.

You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

11.951

Earnings Share

(0.76)

Revenue Per Share

13.717

Quarterly Revenue Growth

0.276

Return On Assets

(0.1)

The market value of agilon health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilon Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Agilon Net Debt from 2010 to 2024

Latest Agilon Health's Net Debt Growth Pattern

Agilon Net Debt Regression Statistics

Agilon Net Debt History

Other Fundumenentals of agilon health

Agilon Health Net Debt component correlations

About Agilon Health Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY